The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of definitive chemoradiotherapy on quality of life in patients with esophageal cancer: Analysis of the Dutch population-based POCOP registry.
 
Linde Veen
No Relationships to Disclose
 
Marieke Pape
No Relationships to Disclose
 
Maarten C.C.M. Hulshof
No Relationships to Disclose
 
Paul M. Jeene
No Relationships to Disclose
 
Marije Slingerland
No Relationships to Disclose
 
Karen J. Neelis
No Relationships to Disclose
 
Olaf Loosveld
No Relationships to Disclose
 
Tom Rozema
No Relationships to Disclose
 
Mirjam A.G. Sprangers
No Relationships to Disclose
 
Rob Verhoeven
Research Funding - Bristol-Myers Squibb (Inst)
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Astellas Pharma (Inst); Bristol-Myers Squibb; Dragonfly Therapeutics; Merck; Novartis (Inst); Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca